ALDX - Aldeyra Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts5554
Avg. Estimate-0.39-0.42-1.72-2.37
Low Estimate-0.47-0.52-2.17-5.2
High Estimate-0.37-0.37-1.46-1.33
Year Ago EPS-0.37-0.35-1.4-1.72
Revenue EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts5455
Avg. EstimateN/AN/AN/A60k
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/A290k
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History3/30/20176/29/20179/29/201712/30/2017
EPS Est.-0.36-0.39-0.37-0.32
EPS Actual-0.37-0.35-0.32-0.36
Difference-0.010.040.05-0.04
Surprise %-2.80%10.30%13.50%-12.50%
EPS TrendCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.39-0.42-1.72-2.37
7 Days Ago-0.39-0.42-1.72-2.51
30 Days Ago-0.41-0.42-1.53-2.25
60 Days Ago-0.41-0.42-1.57-2.11
90 Days Ago-0.41-0.42-1.58-1.92
EPS RevisionsCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days1N/A22
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesALDXIndustrySectorS&P 500
Current Qtr.-5.40%N/AN/A0.42
Next Qtr.-20.00%N/AN/A0.38
Current Year-22.90%N/AN/A0.20
Next Year-37.80%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.12
Past 5 Years (per annum)N/AN/AN/AN/A